/term/net-intangibles-purchase-and-sale/ROCO:6589 EirGenix (ROCO:6589) Net Intangibles Purchase And Sale
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Net Intangibles Purchase And Sale

EirGenix (ROCO:6589) Net Intangibles Purchase And Sale : NT$-19 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

EirGenix's net Intangibles purchase and sale for the three months ended in Mar. 2024 was NT$-4 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-19 Mil.

EirGenix Net Intangibles Purchase And Sale Historical Data

The historical data trend for EirGenix's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Net Intangibles Purchase And Sale Chart

EirGenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Intangibles Purchase And Sale
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.27 -4.87 -3.02 -8.65 -15.14

EirGenix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Intangibles Purchase And Sale Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.19 -10.36 -3.59 -3.92

EirGenix Net Intangibles Purchase And Sale Calculation

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EirGenix Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of EirGenix's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

EirGenix (ROCO:6589) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Net Intangibles Purchase And Sale
Comparable Companies
ROCO:6547 ROCO:6919 ROCO:4147 ROCO:6617 ROCO:4174 ROCO:6976 ROCO:4162 ROCO:6712 ROCO:6586 TPE:4142 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
Website
https://www.eirgenix.com
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix (ROCO:6589) Headlines

No Headlines